Pyxis Oncology is trading 5.11% down now at $3.06 as broader markets weaken amid renewed Middle East tensions, higher oil prices, and concerns about a more hawkish Federal Reserve.
- The S&P 500 is down 0.50%, the Nasdaq Composite 0.44%, and the Dow 0.67%, supporting a global risk-off explanation.
- A recently registered resale of up to 39.2 million shares may also weigh on sentiment.
- No new company-specific announcement was found for August 31, 2026.